{"id":"https://genegraph.clinicalgenome.org/r/f8c26573-4385-46bc-9daf-7f6522d56811v1.0","type":"EvidenceStrengthAssertion","dc:description":"Human pathogenic *AGPAT2* variants were first reported in 2002 in association with autosomal recessive congenital generalized lipodystrophy (Agarwal et al, PMID:11967537). We have curated the inheritance pattern for *AGPAT2* - related lipodystrophy as autosomal recessive because a recessive mode of inheritance has been consistently reported since 2002 (Agarwal et al, PMIDs:12765973; 11967537; Gorin et al, PMID:32412105). \n\nHomozygous or compound heterozygous variants, including nonsense, splice site, frameshift variants and small deletions have been reported. Typical autosomal recessive cases due to homozygous or compound heterozygous variants presented with hypertriglyceridemia, hepatic steatosis, hyperinsulinemia, pancreatitis and diabetes mellitus features even in early childhood and adolescence (Magre et al, PMID: 12765973; Gorin et al et al, PMID:32412105; Abuzenadah et al, PMID:38231342).   \n\nAt least 50 lipodystrophy-causing *AGPAT2* variants (primarily nonsense or frameshift) have been reported in humans. Evidence supporting the association of this gene with lipodystrophy includes case-level data, segregation data, and experimental data. The aggregated score for case-level and segregation data is 12 points. Variants in this gene were curated for this summary in 12 probands in 8 publications (PMIDs: 38231342,35474974, 32153340, 32412105, 32280377, 23430550, 22902344,12765973), with cases presenting as congenital, generalized lipodystrophy. More evidence is available to support the gene-disease association in the literature, but as the maximum score for genetic evidence (12 points) has been reached; this has not been curated exhaustively. This gene-disease relationship is supported by functional assays (both individual and massively parallel), knockout mouse models, expression studies and functional alterations (PMIDs: 21051554, 38127985, 27408775, 37752957, 38623324). Total points for the experimental evidence are 5. Total points for genetic and experimental evidence together are 17.\n\nPer criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no differences in inheritance pattern and phenotypic variability. Therefore, we curated AGPAT2 as associated with autosomal recessive congenital, generalized lipodystrophy (OMIM: 608594) and have been lumped in a single gene curation of lipodystrophy (MONDO: 0006573).  \n\nIn summary, *AGPAT2* is definitively associated with autosomal recessive, congenital generalized lipodystrophy from birth or early infancy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.\n\nThis classification was approved by the ClinGen Monogenic Diabetes GCEP on November 13, 2024 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f8c26573-4385-46bc-9daf-7f6522d56811","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-11-13T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10016","date":"2024-11-14T01:22:38.192Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e446d7e-2539-4799-a951-ead229a73679_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34a876b6-8ac8-47c8-ac61-f678414799b9","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34a876b6-8ac8-47c8-ac61-f678414799b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32153340","allele":{"id":"https://genegraph.clinicalgenome.org/r/76eadc53-a026-46e7-9cea-f89d5c4d41a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.335del (p.Pro112ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915945822"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7e446d7e-2539-4799-a951-ead229a73679","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32153340","rdfs:label":"Rubaie Case","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/76eadc53-a026-46e7-9cea-f89d5c4d41a9"},"detectionMethod":"AGPAT2 sequencing","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000831","obo:HP_0002240","obo:HP_0003712","obo:HP_0000822","obo:HP_0009125","obo:HP_0002155","obo:HP_0000956"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/34a876b6-8ac8-47c8-ac61-f678414799b9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f5865231-c634-4e7c-82c2-50139ad6ff32_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec09e3c5-19eb-4ae1-8346-1d130408a5c1","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec09e3c5-19eb-4ae1-8346-1d130408a5c1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22902344","allele":{"id":"https://genegraph.clinicalgenome.org/r/35fdc5b2-5a4e-433f-80c4-e995db845b43","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.685G>T (p.Glu229Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375577678"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f5865231-c634-4e7c-82c2-50139ad6ff32","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22902344","rdfs:label":"Haghighi case1 ","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/35fdc5b2-5a4e-433f-80c4-e995db845b43"},"detectionMethod":"Six exons and the flanking sequence of the AGPAT2 gene were PCR amplified and direct sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0007552","obo:HP_0001744","obo:HP_0008968","obo:HP_0009125","obo:HP_0002240","obo:HP_0003124","obo:HP_0002155"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec09e3c5-19eb-4ae1-8346-1d130408a5c1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7d8aa10c-fb8d-4e9a-9b55-7001897d908c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/043d672c-2dde-415f-9bbb-d2f098c6b195","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/043d672c-2dde-415f-9bbb-d2f098c6b195_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35474974","allele":{"id":"https://genegraph.clinicalgenome.org/r/8641373c-4c97-4444-9cca-701f23b4d0a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.158del (p.Gly53AlafsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573053146"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/7d8aa10c-fb8d-4e9a-9b55-7001897d908c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35474974","rdfs:label":"Hummadi proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8641373c-4c97-4444-9cca-701f23b4d0a8"},"detectionMethod":"Sanger sequencing and molecular analysis of the AGPAT2 gene","firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/043d672c-2dde-415f-9bbb-d2f098c6b195_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32170066-9dfc-49a6-afbe-bf511bf960fe_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré family 155","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/32170066-9dfc-49a6-afbe-bf511bf960fe","type":"Family","rdfs:label":"Magré family 155","member":{"id":"https://genegraph.clinicalgenome.org/r/bae117ed-590f-4bc8-8d2b-18f14117cd77","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré proband155","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/503d3c5a-6fce-4670-b491-3a54da000fc1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.317-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375583045"}},"detectionMethod":"AGPAT1 and AGPAT2 exons and splice junctions were PCR amplified and Sanger sequenced using Big Dye terminator chemistry.","firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5c35b0e8-c1aa-4306-8b51-6d5be7734a1c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","allele":{"id":"https://genegraph.clinicalgenome.org/r/503d3c5a-6fce-4670-b491-3a54da000fc1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000831","obo:HP_0000956","obo:HP_0001397","obo:HP_0009125","obo:HP_0000822","obo:HP_0007552","obo:HP_0002155"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bae117ed-590f-4bc8-8d2b-18f14117cd77"}},{"id":"https://genegraph.clinicalgenome.org/r/b283d205-7b25-4ef8-914f-97163ba37727_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré family 101","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/b283d205-7b25-4ef8-914f-97163ba37727","type":"Family","rdfs:label":"Magré family 101","member":{"id":"https://genegraph.clinicalgenome.org/r/3868fd44-6315-4953-8bd1-3a8ecef75eee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré proband 101","ageType":"AgeAtOnset","ageUnit":"Days","allele":{"id":"https://genegraph.clinicalgenome.org/r/503d3c5a-6fce-4670-b491-3a54da000fc1"},"detectionMethod":"AGPAT1 and AGPAT2 exons and splice junctions were PCR amplified and Sanger sequenced using Big Dye terminator chemistry.","firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ce887bb-569d-40ab-b927-79b40b6f2268_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","allele":{"id":"https://genegraph.clinicalgenome.org/r/503d3c5a-6fce-4670-b491-3a54da000fc1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0009125","obo:HP_0002155","obo:HP_0007552","obo:HP_0001397","obo:HP_0000831","obo:HP_0000956","obo:HP_0000822"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3868fd44-6315-4953-8bd1-3a8ecef75eee"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e29430a6-3702-49c3-9ad4-40af3f9e5d21_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38231342","rdfs:label":"Abuzenadah family 5","family":{"id":"https://genegraph.clinicalgenome.org/r/e29430a6-3702-49c3-9ad4-40af3f9e5d21","type":"Family","rdfs:label":"Abuzenadah family 5","member":{"id":"https://genegraph.clinicalgenome.org/r/133281f8-2a82-4e4e-8073-394954237003","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38231342","rdfs:label":"Proband LF05.3","allele":{"id":"https://genegraph.clinicalgenome.org/r/8641373c-4c97-4444-9cca-701f23b4d0a8"},"detectionMethod":"AGPAT2 sequecning","firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/dd496859-d5e1-4727-8681-de07803e8d85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38231342","allele":{"id":"https://genegraph.clinicalgenome.org/r/8641373c-4c97-4444-9cca-701f23b4d0a8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001397","obo:HP_0000831","obo:HP_0002155","obo:HP_0000822","obo:HP_0000956","obo:HP_0007552","obo:HP_0009125"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/133281f8-2a82-4e4e-8073-394954237003"}},{"id":"https://genegraph.clinicalgenome.org/r/e17b63be-0b6d-4f3a-bb21-49a9020587a7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré family 142","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/e17b63be-0b6d-4f3a-bb21-49a9020587a7","type":"Family","rdfs:label":"Magré family 142","member":{"id":"https://genegraph.clinicalgenome.org/r/9615685e-3849-4d3a-ad52-dacd60215c6c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","rdfs:label":"Magré proband 142","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7a6c1440-e70a-44bf-9f86-2df5593d7f1f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.661+2T>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042194"}},"detectionMethod":"AGPAT1 and AGPAT2 exons and splice junctions were PCR amplified and Sanger sequenced using Big Dye terminator chemistry.","firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d1aad8f3-3860-45a2-902c-9e28875fe396_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12765973","allele":{"id":"https://genegraph.clinicalgenome.org/r/7a6c1440-e70a-44bf-9f86-2df5593d7f1f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0009125","obo:HP_0000822","obo:HP_0000956","obo:HP_0002155","obo:HP_0000831","obo:HP_0007552","obo:HP_0001397"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9615685e-3849-4d3a-ad52-dacd60215c6c"}},{"id":"https://genegraph.clinicalgenome.org/r/0f518b89-324d-4787-8258-2ba33ec4417b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32412105","rdfs:label":"Gorin Family","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/0f518b89-324d-4787-8258-2ba33ec4417b","type":"Family","rdfs:label":"Gorin Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8345d19a-7ce9-4eb0-9409-99208c535cc4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32412105","rdfs:label":"Proband II-3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/267cbf7d-975d-47a1-9588-ebdcbdad60a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000009.12:g.136673928del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5342858"}},"detectionMethod":"whole exome sequencing","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/efb1770c-d4eb-48e6-80a8-c39c9478daf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32412105","allele":{"id":"https://genegraph.clinicalgenome.org/r/267cbf7d-975d-47a1-9588-ebdcbdad60a6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0000831","obo:HP_0000956","obo:HP_0001433","obo:HP_0009125","obo:HP_0002155","obo:HP_0000822","obo:HP_0007552"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8345d19a-7ce9-4eb0-9409-99208c535cc4"},"publishedLodScore":2.4,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/df5e8a7c-61bb-49cd-b768-a7a92e62f88d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35474974","rdfs:label":"Hummadi family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/df5e8a7c-61bb-49cd-b768-a7a92e62f88d","type":"Family","rdfs:label":"Hummadi family","member":{"id":"https://genegraph.clinicalgenome.org/r/7d8aa10c-fb8d-4e9a-9b55-7001897d908c"}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0007552","obo:HP_0000831","obo:HP_0009125","obo:HP_0002240","obo:HP_0002155","obo:HP_0000956"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7d8aa10c-fb8d-4e9a-9b55-7001897d908c"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/363ac2b0-a842-4f7e-838d-95a11daf6887_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d254eff1-6620-4ef9-b14b-10d82e75c2cb","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d254eff1-6620-4ef9-b14b-10d82e75c2cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32280377","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a2b1aab-15ca-4e68-a4f3-b7c5e47586c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.369_372del (p.Leu124SerfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2497275545"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/363ac2b0-a842-4f7e-838d-95a11daf6887","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32280377","rdfs:label":"Montenegro patient 2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3a2b1aab-15ca-4e68-a4f3-b7c5e47586c6"},"detectionMethod":"gDNA extaction from pheripheral blood leucocytes. The entire coding regions and intron–exon junctions of AGPAT2 and BSCL2 were amplified by polymerase chain reactions (PCR) using specific primers and were automatically sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002155","obo:HP_0000831","obo:HP_0002240","obo:HP_0000956","obo:HP_0007552","obo:HP_0009125"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d254eff1-6620-4ef9-b14b-10d82e75c2cb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8345d19a-7ce9-4eb0-9409-99208c535cc4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efb1770c-d4eb-48e6-80a8-c39c9478daf2","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efb1770c-d4eb-48e6-80a8-c39c9478daf2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/8345d19a-7ce9-4eb0-9409-99208c535cc4"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bae117ed-590f-4bc8-8d2b-18f14117cd77_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c35b0e8-c1aa-4306-8b51-6d5be7734a1c","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c35b0e8-c1aa-4306-8b51-6d5be7734a1c_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bae117ed-590f-4bc8-8d2b-18f14117cd77"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a54c31a5-5fde-43ad-8d71-8c35ee389df8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17851721-ea6b-4fb0-9a09-8529ef32e763","type":"EvidenceLine","dc:description":"Homozygous, inherited missense variant with supportive functional\nevidence will be scored 1 point","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17851721-ea6b-4fb0-9a09-8529ef32e763_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cys48Arg AGPAT2 proteins stably transfected into 3T3-L1 cells showed significantly reduced expression and enzymatic activity compared to wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/17851721-ea6b-4fb0-9a09-8529ef32e763_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430550","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9e70667-ae39-4e54-a390-c173c7300804","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.142T>C (p.Cys48Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375587976"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a54c31a5-5fde-43ad-8d71-8c35ee389df8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23430550","rdfs:label":"Ramanathan Patient A","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c9e70667-ae39-4e54-a390-c173c7300804"},"detectionMethod":"Genomic DNA was extracted from peripheral blood leukocytes.\nPCR amplification and direct sequencing were performed for AGPAT2 and BSCL2 genes","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002155","obo:HP_0001007","obo:HP_0009125","obo:HP_0000822","obo:HP_0000956","obo:HP_0003712","obo:HP_0000831"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/17851721-ea6b-4fb0-9a09-8529ef32e763_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f24aa862-d13a-4530-ac4e-574d5867770d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3af4862-d9d2-4b8f-88e1-fa41b1606dbf","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3af4862-d9d2-4b8f-88e1-fa41b1606dbf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32280377","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0c282fa-55cf-40c4-9f6d-ad8b650f9eb3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.589-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277944"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4e9ffa4d-7448-41b4-9a53-288f11adc498","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e9ffa4d-7448-41b4-9a53-288f11adc498_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32280377","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a2b1aab-15ca-4e68-a4f3-b7c5e47586c6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f24aa862-d13a-4530-ac4e-574d5867770d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32280377","rdfs:label":"Montenegro patient 1","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3a2b1aab-15ca-4e68-a4f3-b7c5e47586c6"},{"id":"https://genegraph.clinicalgenome.org/r/a0c282fa-55cf-40c4-9f6d-ad8b650f9eb3"}],"detectionMethod":"gDNA extaction from pheripheral blood leucocytes. The entire coding regions and intron–exon junctions of AGPAT2 and BSCL2 were amplified by polymerase chain reactions (PCR) using specific primers and were automatically sequenced.\n\n","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0007552","obo:HP_0009125","obo:HP_0002155","obo:HP_0001733","obo:HP_0000831","obo:HP_0000488","obo:HP_0000822"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4e9ffa4d-7448-41b4-9a53-288f11adc498_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b3af4862-d9d2-4b8f-88e1-fa41b1606dbf_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c59ab59e-bb27-4dc7-b5f9-f169c9943e2c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ccb9bed-b4ec-4eb2-b713-0cc74a7b0fe9","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ccb9bed-b4ec-4eb2-b713-0cc74a7b0fe9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22902344","allele":{"id":"https://genegraph.clinicalgenome.org/r/363ca96f-ca14-431f-984d-c47ba19cc202","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006412.4(AGPAT2):c.514G>A (p.Glu172Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5342949"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c59ab59e-bb27-4dc7-b5f9-f169c9943e2c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22902344","rdfs:label":"Haghighi case 2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/363ca96f-ca14-431f-984d-c47ba19cc202"},"detectionMethod":"Six exons and the flanking sequence of the AGPAT2 gene were PCR amplified and direct sequenced.","firstTestingMethod":"PCR","phenotypes":["obo:HP_0003124","obo:HP_0009125","obo:HP_0002240","obo:HP_0007552","obo:HP_0008968","obo:HP_0002155"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3ccb9bed-b4ec-4eb2-b713-0cc74a7b0fe9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/133281f8-2a82-4e4e-8073-394954237003_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd496859-d5e1-4727-8681-de07803e8d85","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd496859-d5e1-4727-8681-de07803e8d85_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/133281f8-2a82-4e4e-8073-394954237003"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3868fd44-6315-4953-8bd1-3a8ecef75eee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ce887bb-569d-40ab-b927-79b40b6f2268","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ce887bb-569d-40ab-b927-79b40b6f2268_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3868fd44-6315-4953-8bd1-3a8ecef75eee"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9615685e-3849-4d3a-ad52-dacd60215c6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1aad8f3-3860-45a2-902c-9e28875fe396","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d1aad8f3-3860-45a2-902c-9e28875fe396_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9615685e-3849-4d3a-ad52-dacd60215c6c"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccb7250b-60d3-451c-81d0-7f5b3988f71d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b93295c1-5aa2-426e-a172-05c1c4c29b25","type":"Finding","dc:description":"Lysophosphatidic acid is a key mediator of liver and white adipose tissue inflammation and lipodystrophy due to AGPAT2 deficiency as well as liver inflammation due to overnutrition","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38127985","rdfs:label":"Knockdown expression of Agpat2 in the rat","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ddca73d7-1c50-45e4-9eff-285145419c1d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8002b4f8-dbaf-45a8-8b7e-e45b437b9739","type":"Finding","dc:description":"Similar to human BSCL patients, Agpat2–/– null mice develop a syndrome characterized by severe insulin resistance, hepatic steatosis, and lipoatrophic diabetes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21051554","rdfs:label":"AGPAT2 Knockout mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/104beaeb-7d02-4df6-ad44-6eb02960d8bc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48354678-73ba-45de-9a4c-16bfaae4e22e","type":"Finding","dc:description":"Turning off the expression of human AGPAT2 in vivo resulted in total loss of adipose tissue in the mice. Conversely, re-expressing human AGPAT2 in both sexes of Agpat2-null mice resulted in partial regeneration of both white and brown adipose tissue.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38127985","rdfs:label":"AGPAT2 Knockout mice using an antisense oligonucleotide","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/87e2f2e0-548b-4e95-b524-eec8c3d34468","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fbfd284-90e6-4cef-9b92-e92444631b6c","type":"Finding","dc:description":"The primary objective of this study was to determine whether regulated Adipose tissue (AT) regeneration starting embryonically in dox-fed Tg-AT-hA2;mA2-/- mice could result in the amelioration of hepatic steatosis and other metabolic derangements compared to that in chow-fed Tg-AT-hA2;mA2-/- mice.\nThe study results showed that regulated Adipose tissue (AT) regeneration in doxycycline (dox)-fed Tg-AT-hAGPAT2;mAgpat2-/- mice partially ameliorates hepatic steatosis at 12 weeks of age and causes reduced expression of genes involved in hepatic de novo lipogenesis despite partial (~30–50%) AT regeneration compared to that in wild-type mice. \nCompared to chow-fed Tg-AT-hAGPAT2;mAgpat2-/- mice, those fed dox diet had markedly reduced serum insulin levels, suggesting an improvement in insulin resistance. Interestingly, the fasting plasma glucose levels in dox-fed Tg-AT-hAGPAT2;mAgpat2-/- mice were no different than those in chow-fed wild-type mice.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38623324","rdfs:label":"Partial AT regeneration in lipodystrophic mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/dc362479-0d3b-4178-9e29-61f4d11899bb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02197c39-ff69-466a-8483-46f866b6b43c","type":"Finding","dc:description":"In both sexes of Agpat2-/- null mice, adipose-tissue-specific re-expression of hAGPAT2 resulted in partial regeneration of white and brown adipose tissue (but only 30%–50% compared with wild-type mice, which had molecular signatures of adipocytes, including leptin secretion. This suggests an important role of Agpat2 in adipocyte differentiation. Knockdown of hAGPAT2 expression in vivo resulted in total loss of regenerated adipose tissue, clear evidence that Agpat2 is essential for adipocyte differentiation in vivo.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37752957","rdfs:label":"Over expression of human AGPAT2 in Agpat2 null mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae2dfd23-d565-43ba-ac66-99457450ce6d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7905d789-4d29-4d3a-97f5-f976bdb478ed","type":"FunctionalAlteration","dc:description":"This study were aimed to characterize morphological, ultrastructural, and molecular changes of Adipose tissue(AT) from Agpat2-/- mice and to assess adipogenic differentiation in Agpat2-/-mouse embryonic fibroblasts (MEFs).  \nAGPAT2 deficient adult mice are completely devoid of all white adipose tissue (WAT) and brown adipose tissue(BAT) depots. In contrast, fetuses and newborn Agpat2-/- mice have preserved adipose tissue. However, lipodystrophy results from massive adipocyte death and inflammatory infiltration of the adipose tissue during the first week of life was observed.  At the ultrastructural level, white adipocytes in newborn Agpat2-/- were smaller and had a marked reduction of plasma membrane caveolae, abnormally structured mitochondria and irregular LDs. In addition, enhanced accumulation of autophagic structures observed in Agpat2-/-adipocytes. In vitro studies showed that Agpat2-/- MEF cells display impaired adipogenesis, characterized by a reduced number of adipocytes and ultrastructural abnormalities in lipid droplets, mitochondria, and plasma membrane. Overexpression of PPARg increase the number of Agpat2-/- MEFs that differentiated into adipocyte-like cells but did not prevent morphological abnormalities and cell death.\nThis study concludes that lipodystrophy in Agpat2 -/- mice results from postnatal cell death of adipose tissue in combination with acute local inflammation AGPAT2 deficient adipocytes may have altered fat deposition or reduced ability to remodel massive fat availability associated with postnatal feeding.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27408775","rdfs:label":"Role of AGPAT2 in adipose tissue dynamics "}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dfa30e7e-e750-4b65-bcd5-9421cc34fc43_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22bed18a-f8cb-4500-9c86-fbe881de4cda","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73d6cc11-5b59-479f-8432-f449b0112c7e","type":"Finding","dc:description":"https://www.ncbi.nlm.nih.gov/gene/10555","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"AGPAT2 Expression_NCBI gene","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":9331,"specifiedBy":"GeneValidityCriteria11","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/INlrmpVXaXY","type":"GeneValidityProposition","disease":"obo:MONDO_0006573","gene":"hgnc:325","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_dfa30e7e-e750-4b65-bcd5-9421cc34fc43-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}